172 related articles for article (PubMed ID: 24744144)
1. LDH5 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.
Yao Y; Wang H; Li B
Tumour Biol; 2014 Jul; 35(7):6973-81. PubMed ID: 24744144
[TBL] [Abstract][Full Text] [Related]
2. Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma.
Grimm M; Alexander D; Munz A; Hoffmann J; Reinert S
Clin Exp Metastasis; 2013 Apr; 30(4):529-40. PubMed ID: 23184277
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
Giatromanolaki A; Gkegka AG; Pouliliou S; Biziota E; Kakolyris S; Koukourakis M
Breast Cancer Res Treat; 2022 Jul; 194(1):13-23. PubMed ID: 35482128
[TBL] [Abstract][Full Text] [Related]
5. High lactate dehydrogenase 5 expression correlates with high tumoral and stromal vascular endothelial growth factor expression in gastric cancer.
Kim HS; Lee HE; Yang HK; Kim WH
Pathobiology; 2014; 81(2):78-85. PubMed ID: 24401755
[TBL] [Abstract][Full Text] [Related]
6. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis.
Kolev Y; Uetake H; Takagi Y; Sugihara K
Ann Surg Oncol; 2008 Aug; 15(8):2336-44. PubMed ID: 18521687
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer.
Koukourakis MI; Kakouratos C; Kalamida D; Bampali Z; Mavropoulou S; Sivridis E; Giatromanolaki A
Int J Radiat Biol; 2016 Jul; 92(7):353-63. PubMed ID: 27010533
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy.
Koukourakis MI; Giatromanolaki A; Winter S; Leek R; Sivridis E; Harris AL
Oncology; 2009; 77(5):285-92. PubMed ID: 19923867
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of HIF-1α expression in patients with gastric cancer.
Zhu CL; Huang Q; Liu CH; Lin XS; Xie F
Mol Biol Rep; 2013 Nov; 40(11):6055-62. PubMed ID: 24057269
[TBL] [Abstract][Full Text] [Related]
10. Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1.
Kayser G; Kassem A; Sienel W; Schulte-Uentrop L; Mattern D; Aumann K; Stickeler E; Werner M; Passlick B; zur Hausen A
Diagn Pathol; 2010 Apr; 5():22. PubMed ID: 20385008
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Trarbach T; Folprecht G; Shi MM; Lebwohl D; Jalava T; Laurent D; Meinhardt G; Harris AL
Clin Cancer Res; 2011 Jul; 17(14):4892-900. PubMed ID: 21632858
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.
Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
Leuk Lymphoma; 2008 Nov; 49(11):2181-6. PubMed ID: 19021062
[TBL] [Abstract][Full Text] [Related]
13. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.
Koukourakis MI; Giatromanolaki A; Simopoulos C; Polychronidis A; Sivridis E
Clin Exp Metastasis; 2005; 22(1):25-30. PubMed ID: 16132575
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer.
Yuan C; Li Z; Wang Y; Qi B; Zhang W; Ye J; Wu H; Jiang H; Song LN; Yang J; Cheng J
Histopathology; 2014 Nov; 65(5):595-605. PubMed ID: 24762230
[TBL] [Abstract][Full Text] [Related]
16. The relationship between hypoxia-inducible factor 1α (HIF-1α) and patient survival in breast cancer: Systematic review and meta-analysis.
Shamis SAK; McMillan DC; Edwards J
Crit Rev Oncol Hematol; 2021 Mar; 159():103231. PubMed ID: 33482350
[TBL] [Abstract][Full Text] [Related]
17. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis.
Zheng SS; Chen XH; Yin X; Zhang BH
PLoS One; 2013; 8(6):e65753. PubMed ID: 23799043
[TBL] [Abstract][Full Text] [Related]
20. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases.
Koukourakis MI; Kontomanolis E; Giatromanolaki A; Sivridis E; Liberis V
Gynecol Obstet Invest; 2009; 67(3):162-8. PubMed ID: 19088479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
